Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wroclaw
Clinical trial register · Poland

Clinical Trials in Wroclaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 95 Lodz 80 Krakow 70 Poznan 67 Gdansk 59
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Wroclaw Medical University30 Pfizer29 AstraZeneca26 Eli Lilly and Company22 Janssen Research & Development, LLC20 Clear sponsor filter
Site location
Warsaw95 Lodz80 Krakow70 Poznan67 Gdansk59
All 81 locations
Target enrolment
to

Trials with a site in Wroclaw

26 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
AstraZeneca
Phase 3
750
Gdansk, Gliwice, Kielce, Krakow, Lublin, Wroclaw
2026-09-24
Recruiting
AstraZeneca
Phase 3
1,330
Gdansk, Koszalin, Krakow, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2026-09-15
Recruiting
AstraZeneca
Phase 3
2,800
Olsztyn, Warsaw, Węgrów, Wroclaw, Żywiec
2026-09-01
Recruiting
AstraZeneca
Phase 3
915
Gdansk, Koszalin, Poznan, Siedlce, Skórzewo, Wroclaw
2026-07-16
Recruiting
AstraZeneca
Phase 3
750
Gdansk, Gliwice, Kielce, Lublin, Poznan, Wroclaw
2026-06-26
Recruiting
Ravulizumab Outcomes in Polish Patients With aHUS
NCT07399730Atypical Hemolytic Uremic Syndrome
DrugRavulizumab
AstraZeneca
Observational
80
Gdansk, Katowice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2026-06-24
Recruiting
AstraZeneca
Phase 3
150
Gdansk, Konin, Krakow, Lodz, Lublin, Poznan, Przemyśl, Wroclaw
2026-06-15
Recruiting
AstraZeneca
Phase 3
508
Gdansk, Gliwice, Lublin, Poznan, Warsaw, Wroclaw
2026-02-23
Recruiting
AstraZeneca
Phase 2
320
Krakow, Torun, Warsaw, Wroclaw
2025-12-15
Recruiting
AstraZeneca
Phase 3
420
Kielce, Krakow, Lodz, Lublin, Wroclaw
2025-11-11
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Bydgoszcz, Chojnice, Krakow, Lublin, Poznan, Sopot, Warsaw, Wroclaw
2024-08-28
Recruiting
AstraZeneca
Phase 3
620
Bialystok, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Gdansk, Gliwice, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-07
Recruiting
AstraZeneca
Phase 3
240
Bialystok, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2024-06-20
Recruiting
AstraZeneca
Phase 3
100
Lodź, Warsaw, Wroclaw
2024-03-14
Active, closed
AstraZeneca
Phase 3
1,898
Bydgoszcz, Koszalin, Poznan, Rzeszów, Warsaw, Wroclaw
2023-11-21
Recruiting
AstraZeneca
Phase 3
800
Bialystok, Gdansk, Gliwice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2023-09-22
Recruiting
AstraZeneca
Phase 3
3,527
Chrzanów, Lodz, Rzeszów, Warsaw, Wroclaw, Łańcut, Łęczna
2022-12-13
Active, closed
AstraZeneca
Phase 3
644
Bialystok, Bydgoszcz, Lodz, Poznan, Warsaw, Wroclaw
2022-05-16
Active, closed
AstraZeneca
Phase 3
791
Bialystok, Gliwice, Katowice, Lodz, Warsaw, Wroclaw
2022-02-18
Active, closed
AstraZeneca
Phase 3
866
Bydgoszcz, Koszalin, Krakow, Lodz, Rzeszów, Warsaw, Wroclaw
2020-07-24
Active, closed
AstraZeneca
Phase 3
923
Bydgoszcz, Konin, Poznan, Racibórz, Radom, Tomaszów Mazowiecki, Warsaw, Wroclaw
2019-06-25
Active, closed
AstraZeneca
Phase 3
810
Gdansk, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2019-04-16
Active, closed
AstraZeneca
Phase 3
730
Gdansk, Olsztyn, Poznan, Tomaszów Mazowiecki, Warsaw, Wroclaw
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,018
Bialystok, Gdansk, Grudziądz, Koszalin, Piotrkow Trybunalski, Poznan, Warsaw, Wroclaw
2018-05-14
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/wroclaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Wroclaw that also match the filters currently applied.

How many clinical trials are recruiting in Wroclaw?

16 of the 26 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wroclaw), 26 studies
PhaseStudiesRecruitingShare
Phase 3231488.5%
Phase 2217.7%
Observational113.8%

Most active sponsors

Lead sponsors with the most studies (Wroclaw)
Lead sponsorStudiesRecruiting
AstraZeneca2616
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.